ZA200809056B - Influenza virus vaccine - Google Patents

Influenza virus vaccine

Info

Publication number
ZA200809056B
ZA200809056B ZA200809056A ZA200809056A ZA200809056B ZA 200809056 B ZA200809056 B ZA 200809056B ZA 200809056 A ZA200809056 A ZA 200809056A ZA 200809056 A ZA200809056 A ZA 200809056A ZA 200809056 B ZA200809056 B ZA 200809056B
Authority
ZA
South Africa
Prior art keywords
influenza virus
virus vaccine
vaccine
influenza
virus
Prior art date
Application number
ZA200809056A
Other languages
English (en)
Inventor
Larisa Georgievna Rudenko
Julia Desheva
Galina Ibragimovna Alexandrova
Original Assignee
Biodiem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biodiem Ltd filed Critical Biodiem Ltd
Publication of ZA200809056B publication Critical patent/ZA200809056B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA200809056A 2006-04-19 2007-04-18 Influenza virus vaccine ZA200809056B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006113251/13A RU2318871C1 (ru) 2006-04-19 2006-04-19 Штамм вируса гриппа гкв 2389 для получения живой интраназальной и инактивированной гриппозной вакцины

Publications (1)

Publication Number Publication Date
ZA200809056B true ZA200809056B (en) 2010-01-27

Family

ID=38608977

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809056A ZA200809056B (en) 2006-04-19 2007-04-18 Influenza virus vaccine

Country Status (10)

Country Link
US (1) US20090104228A1 (xx)
EP (1) EP2015774A4 (xx)
JP (1) JP2009533477A (xx)
KR (1) KR20090007599A (xx)
AU (1) AU2007240128A1 (xx)
CA (1) CA2649661A1 (xx)
MX (1) MX2008013314A (xx)
RU (1) RU2318871C1 (xx)
WO (1) WO2007118284A1 (xx)
ZA (1) ZA200809056B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2008000747A1 (es) * 2007-03-16 2008-04-25 Wyeth Corp Composicion de vacuna que comprende una primera y una segunda cepa inactivada del virus de la influenza aviar; metodo para vacunar un ave.
WO2010114169A1 (en) * 2009-03-31 2010-10-07 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Method for prophylaxis of influenza using vaccine for intranasal administration
JP5876036B2 (ja) * 2010-05-21 2016-03-02 ノバルティス アーゲー インフルエンザウイルス再集合方法
RU2458124C2 (ru) * 2010-07-20 2012-08-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский Институт гриппа" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ гриппа" Минздравсоцразвития России) ВАКЦИННЫЙ ШТАММ ВИРУСА ГРИППА А(Н3N2)-А/8/Perth/16/2009 ДЛЯ ПРОИЗВОДСТВА ИНАКТИВИРОВАННОЙ ГРИППОЗНОЙ ВАКЦИНЫ
RU2464309C1 (ru) * 2011-05-24 2012-10-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт экспериментальной медицины" СЗО РАМН Штамм вируса гриппа для производства живой и инактивированной гриппозной вакцины
RU2464312C1 (ru) * 2011-06-16 2012-10-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт экспериментальной медицины" СЗО РАМН Реассортантный штамм вируса гриппа rn2/57-human a(h7n2) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации
EA021095B1 (ru) * 2011-06-22 2015-04-30 Республиканское Государственное Предприятие На Праве Хозяйственного Ведения "Научно-Исследовательский Институт Проблем Биологической Безопасности" Комитета Науки Министерства Образования И Науки Способ получения инактивированной цельновирионной гидроокисьалюминиевой вакцины против гриппа а/h1n1
TWI588260B (zh) * 2014-09-04 2017-06-21 國立清華大學 重組神經胺酸酶蛋白及其應用
KR101645230B1 (ko) * 2015-05-04 2016-08-03 가톨릭대학교 산학협력단 바이러스 증식 방법 및 그 응용
KR101906457B1 (ko) * 2016-10-28 2018-10-12 성신여자대학교 산학협력단 H5 조류 인플루엔자 바이러스 유사입자 백신 및 그 제조방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2879182C (en) * 2004-05-25 2017-02-14 Medimmune, Inc. Influenza hemagglutinin and neuraminidase variants

Also Published As

Publication number Publication date
AU2007240128A1 (en) 2007-10-25
WO2007118284A1 (en) 2007-10-25
CA2649661A1 (en) 2007-10-25
RU2318871C1 (ru) 2008-03-10
US20090104228A1 (en) 2009-04-23
KR20090007599A (ko) 2009-01-19
EP2015774A1 (en) 2009-01-21
RU2006113251A (ru) 2007-10-27
JP2009533477A (ja) 2009-09-17
EP2015774A4 (en) 2011-02-09
MX2008013314A (es) 2009-01-27

Similar Documents

Publication Publication Date Title
IL196024A0 (en) Influenza vaccine
PT2043682E (pt) Vacina da influenza
HK1143085A1 (en) Low-additive influenza vaccines
EP2091960A4 (en) PEPTIDE VACCINE AGAINST INFLUENZA VIRUS
HK1149176A1 (en) Vaccines against multiple subtypes of influenza virus
IL193566A0 (en) Hpv-18-based papillomavirus vaccine
EP1984405A4 (en) INFLUENZA ANTIGENS, VACCINE COMPOSITIONS AND ASSOCIATED METHODS
GB0607088D0 (en) Vaccine
ZA200809056B (en) Influenza virus vaccine
IL193661A0 (en) Papillomavirus vaccine
PL1942933T3 (pl) Szczepionki przeciw grypie psów
EP1998814A4 (en) NEW VACCINES AGAINST INFLUENZA M2
PL2358386T3 (pl) Zoptymalizowane szczepionki na grypę
EP2117589A4 (en) FLAVIVIRUS VACCINE VECTOR AGAINST INFLUENZA VIRUS
IL186057A0 (en) RNAi-INDUCING AGENT FOR INFLUENZA VACCINE
EP1871786A4 (en) PEPTIDE VACCINE AGAINST THE GRIPPEVIRUS
ZA201100962B (en) Influenza vaccines
EP2075005A4 (en) SALK VACCINE (IPV) AND AGAINST DIPHTHERIA, STRIPS AND TETANOS (DPT)
EP2097103A4 (en) VACCINE FORMULATIONS AGAINST INFLUENZA
EP2054081A4 (en) VACCINE AGAINST THE JC VIRUS
GB0617602D0 (en) Vaccine
EP2240199A4 (en) INFLUENZA VACCINES
ZA200900062B (en) Influenza vaccine
GB0623218D0 (en) Influenza vaccine
GB0623865D0 (en) Influenza vaccine